The global anti-infective agents market is estimated to have reached $109bn in 2018 and is expected to grow at a CAGR of 4.2% during the forecast period. In 2018, the hospital pharmacy segment dominated the distribution channel of the anti-infective agents market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 154-page report you will receive 127 charts– all unavailable elsewhere.
The 154-page report provides clear detailed insight into the anti-infective agents market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Anti-infective Agents Market forecasts from 2019-2029
• Global Anti-infective Agents Market forecasts from 2019-2029 by Type:
• Antiviral infections
• Antibacterial infections: B-Lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside
• Antifungal infections: Azoles, Echinocandins, Polyenes
• Global Anti-infective Agents Market forecasts from 2019-2029 by Indication:
• Hepatitis Virus Infection
• HIV Infection
• Pneumonia
• Aspergillosis
• Methicillin-resistant Staphylococcus Aureus (MRSA)
• Dermatophytosis
• Tuberculosis
• Respiratory Virus Infection
• Sepsis
• Global Anti-infective Agents Market forecasts from 2019-2029 by Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Sales
• Global Anti-infective Agents Market forecasts from 2019-2029 by regional and national market:
• North America (US, Canada)
• Europe (Germany, UK, France, Rest of Europe)
• Asia Pacific (Japan, China, India, Rest of APAC)
• RoW (Latin America, Middle East and Africa)
• Profiles of the selected leading companies:
• Abbott Laboratories
• Bristol-Myers Squibb
• GlaxoSmithKline (GSK)
• Merck & Co.
• Novartis AG
• Sanofi SA
• Pfizer
• Anti-infective agents R&D Pipeline
• Key Questions Answered by this Report:
• How is the Anti-infective Agents market evolving?
• What is driving and restraining the Anti-infective Agents market dynamics?
• How will each of the submarkets grow over the forecast period and how much revenue will these submarkets account for in 2029?
• How will the market shares for each of the Anti-infective Agents submarkets develop from 2019 to 2029?
• What will be the main driver for the overall market from 2019-2029?
• How will political and regulatory factors influence the regional markets and submarkets?
• How will the market shares of the national markets change by 2029 and which geographical region will lead the market in 2029?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry sector evolve during the period between 2019 and 2029?
Visiongain’s study is intended for anyone requiring commercial analyses for the global anti-infective agents Market. You find data, trends and predictions.
Buy our report today Anti-infective Agents Market Forecast 2019-2029: Anti-viral Infections, Anti-bacterial Infections, Anti-fungal Infections, Hepatitis Virus Infection, HIV Infection, Pneumonia, Aspergillosis, Methicillin-resistant Staphylococcus Aureus (MRSA), Dermatophytosis, Tuberculosis, Respiratory Virus Infection, Sepsis, Hospital Pharmacies, Retail Pharmacies, Online Sales.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Global Anti-infective agents market Overview
1.2 Global Anti-infective agents market Segmentation
1.3 Overview of Findings
1.4 Structure of the Report
1.5 Why You Should Read This Report
1.6 Key Questions Answered by This Analytical Report
1.7 Who is This Report For?
1.8 Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Anti-infectives
2.1 What Are Anti-infectives?
2.2 Characteristics of Anti-infective agents
2.3 Rare Disease Facts and Statistics
2.4 Common Infectious Diseases Worldwide
2.5 Types of Anti-infectives
2.5.1 Anti-bacterial Drugs
2.5.2 Anti-fungal drugs
2.5.3 Anti-viral drugs
3. Anti-infectives: World Market 2019-2029
3.1 Anti-infective agents market Overview, 2018
3.2 The World Anti-infective Agents market
3.3 World Anti-infective Agents market: Sales Forecast 2019-2029
3.4 Changing Market Shares by Region 2018-2029
4. Anti-infectives: Qualitative Analysis 2019-2029
4.1 Anti-infective Agents Market: Drivers 2019-2029
4.1.1 Increase in Prevalence of Infectious Diseases
4.1.2 High Investment in Anti-infective agents R&D
4.1.3 Growing Support of Government
4.2 Anti-infective agents market Restraints: 2019-2029
4.2.1 Challenges in Research and Development
4.2.2 Stringent Government Regulations
5. Anti-infective Agents Market by Indication, 2019-2029
5.1 Market Overview
5.2 Market Forecast 2019-2029
5.2.1 Hepatitis Virus Infection: Market Forecast, 2019-2029
5.2.2 HIV Infection: Market Forecast, 2019-2029
5.2.3 Pneumonia: Market Forecast, 2019-2029
5.2.4 Aspergillosis: Market Forecast, 2019-2029
5.2.5 Methicillin-resistant Staphylococcus Aureus (MRSA): Market Forecast, 2019-2029
5.2.6 Dermatophytosis: Market Forecast, 2019-2029
5.2.7 Tuberculosis: Market Forecast, 2019-2029
5.2.8 Respiratory Virus Infection: Market Forecast, 2019-2029
5.2.9 Sepsis: Market Forecast, 2019-2029
6. Anti-infective Agents Market by Type, 2019-2029
6.1 Market Overview
6.2 Market Forecast 2019-2029
6.3 Antiviral Infections Market
6.4 Antibacterial Infection Market
6.4.1 B-Lactams Market
6.4.2 Quinolones Market
6.4.3 Macrolides Market
6.4.4 Tetracycline Market
6.4.5 Aminoglycoside Market
6.5 Antifungal infection Market
6.5.1 Azoles Market
6.5.2 Echinocandins Market
6.5.3 Polyenes Market
7. Anti-infective Agents Market by Distribution Channel 2019-2029
7.1 Market Overview
7.2 Market Forecast 2019-2029
7.3 Hospital Pharmacies
7.4 Retail Pharmacies
7.5 Online Sales
8. Anti-infective Agents market - Pipeline Analysis 2019-2029
8.1 Antibacterials in Development
8.2 Antifungals in Development
8.3 Antivirals in development
9. Leading National Markets 2019-2029
9.1 Geographical Breakdown of the World Anti-infective Agents market
9.2 Global Anti-infective Agents market: Regional Forecast 2019-2029
9.3 How Will Regional Market Shares Change to 2029?
9.4 North America Anti-infective Agents market, 2019-2029
9.4.1 US Anti-infective Agents Market Forecast 2019-2029
9.4.2 Canada Anti-infective Agents Market Forecast 2019-2029
9.5 Europe Anti-infective Agents market, 2019-2029
9.5.1 Europe Anti-infective agents market Forecast 2019-2029
9.5.2 Germany Anti-infective Agents Market Forecast 2019-2029
9.5.3 UK Anti-infective Agents Market Forecast 2019-2029
9.5.4 French Anti-infective Agents Market Forecast 2019-2029
9.5.5 Rest of Europe Anti-infective Agents Market Forecast 2019-2029
9.6 Asia-Pacific Anti-infective Agents Market 2019-2029
9.6.1 Japanese Anti-infective Agents Market Forecast 2019-2029
9.6.2 Chinese Anti-infective Agents Market 2019-2029
9.6.3 Indian Anti-infective Agents Market 2019-2029
9.6.4 Rest of APAC Anti-infective Agents Market Forecast 2019-2029
9.7 RoW Anti-infective Agents Market 2019-2029
9.7.1 Latin American Anti-infective Agents Market Forecast 2019-2029
9.7.2 MEA Anti-infective Agents Market 2019-2029
10. Anti-infective Agents Market: Qualitative Analysis, 2019-2029
10.1 Anti-infective Agents Market: SWOT Analysis, 2019-2029
10.1.1 Strengths
10.1.1.1 Promising Anti-infective Drugs R&D Pipeline
10.1.1.2 Increase in incidence of infectious diseases and healthcare awareness
10.1.2 Weaknesses
10.1.3 High Research and Development Cost
10.1.4 Opportunities
10.1.5 Demand from Emerging Market Continues
10.1.6 Increase in Government Support
10.1.7 Threats
10.1.8 Uncertainty of R&D Results
10.1.9 Barriers to Market Entry
10.2 Anti-infective Agents Market: Porters Five Forces Analysis, 2019-2029
10.2.1 Bargaining Power of Supplier: Moderate
10.2.2 Bargaining Power of Buyer: Medium
10.2.3 Competitive Rivalry: Medium
10.2.4 The Threat of New Entrants: Low
10.2.5 Threat of Substitutes: Medium
11. Company Profiles
11.1 Pfizer
11.1.1 Financial Overview
11.1.2 Recent Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Financial Overview
11.2.2 Recent Developments
11.3 Merck & Co., Inc.
11.3.1 Financial Overview
11.3.2 Recent Developments
11.4 Novartis AG
11.4.1 Financial Overview
11.5 Sanofi S.A.
11.5.1 Financial Overview
11.5.2 Recent Developments
11.6 GlaxoSmithKline Inc
11.6.1 Company Overview
11.6.2 Operating Segments
11.6.3 Financial Highlights
11.6.4 Recent Developments
11.7 Abbott Laboratories
11.7.1 Sales and Recent Performance Analysis
12. Conclusion
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Report Evaluation Form
List of Table
Table 3.1 Global Anti-infective agents market Forecast Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 5.1 Global Anti-infective Agents Market Forecast by Indication: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 5.2 Global Hepatitis Virus Infection Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 5.3 Global HIV Infection Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 5.4 Global Pneumonia Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 5.5 Global Aspergillosis Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 5.6 Global MRSA Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 5.7 Global Dermatophytosis Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 5.8 Global Tuberculosis Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 5.9 Global Respiratory Virus Infection Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 5.10 Global Sepsis Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 6.1 Global Anti-infective Agents Market Forecast by Type: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 6.2 Global Antiviral Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 6.3 Global Antibacterial infection Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 6.4 Global B-lactams Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 6.5 Global Quinolones Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 6.6 Global Macrolides Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 6.7 Global Tetracycline Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 6.8 Global Aminoglycoside Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 6.9 Global Antifungal infection Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 6.10 Global Azoles Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 6.11 Global Echinocandins Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 6.12 Global Polyenes Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 7.1 Global Anti-infective agents market Forecast by Distribution Channel: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 7.2 Global Hospital Pharmacies Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 7.3 Global Retail Pharmacies Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 7.4 Global Online Sales Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 9.1 World Anti-infective Agents Market by Region: Revenue ($bn) and Market Share (%) 2018 and 2029
Table 9.2 Global Anti-infective Agents Market Forecast by Region: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.3 North America Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.4 North America Anti-infective Agents Market by Region Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.5 US Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.6 Canada Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.7 Europe Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.8 Europe Anti-infective Agents Market Forecast by Country: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.9 Germany Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.10 UK Anti-infective agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.11 French Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.12 Rest of Europe Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.13 Asia-Pacific Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 9.14 Asia-Pacific Anti-infective Agents Market Forecast by Country: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.15 Japanese Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.16 Chinese Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.17 Indian Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.18 Rest of APAC Anti-infective agents market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.19 Latin American Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.20 MEA Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 11.1 Overview: Pfizer
Table 11.2 Overview: Bristol-Myers Squibb Company
Table 11.3 Overview: Merck & Co., Inc
Table 11.4 Overview: Novartis
Table 11.5 Overview: Sanofi S.A.
Table 11.6 GSK Operating Segments
Table 11.7 GSK: Revenue ($m), R&D ($m), 2016-2018
Table 11.8 Abbott: Key Facts, 2017
Table 11.9 Abbott: Net Sales ($bn) and Revenue Shares (%) by Business Segment, 2017
List of Figure
Figure 1.1 Global Anti-infective agents market Segmentation Overview, 2018
Figure 3.1 Global Anti-infective agents market Forecast Revenue ($bn), AGR (%) 2019-2029
Figure 3.2 Global Anti-infective Agents Market Forecast Share (%) by Region 2018-2029
Figure 4.1 Anti-infective agents market: Drivers 2019-2029
Figure 4.2 Anti-infective agents market: Restraints 2019-2029
Figure 5.1 Global Anti-infective Agents by Indication: Market Share Forecast (%) 2018-2029
Figure 5.2 Global Anti-infective Agents Market Forecast by Indication: Market Shares (%), 2018
Figure 5.3 Global Anti-infective Agents Market Forecast by Indication: Market Shares (%), 2019
Figure 5.4 Global Anti-infective Agents Market Forecast by Indication: Market Shares (%), 2024
Figure 5.5 Global Anti-infective Agents Market Forecast by Indication: Market Shares (%), 2029
Figure 5.6 Global Hepatitis Virus Infection Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 5.7 Global HIV Infection Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 5.8 Global Pneumonia Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 5.9 Global Aspergillosis Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 5.10 Global MRSA Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 5.11 Global Dermatophytosis Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 5.12 Global Tuberculosis Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 5.13 Global Respiratory Virus Infection Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 5.14 Global Sepsis Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 6.1 Global Anti-infective agents market Forecast by Type Market Share (%) 2019-2029
Figure 6.2 Global Anti-infective Agents Market Forecast by Type: Market Shares (%), 2018
Figure 6.3 Global Anti-infective Agents Market Forecast by Type: Market Shares (%), 2024
Figure 6.4 Global Anti-infective Agents Market Forecast by Type: Market Shares (%), 2029
Figure 6.5 Global Antiviral Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 6.6 Global Antibacterial infection Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 6.7 Global B-Lactams Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 6.8 Global Quinolones Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 6.9 Global Macrolides Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 6.10 Global Tetracycline Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 6.11 Global Aminoglycoside Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 6.12 Global Antifungal infection Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 6.13 Global Azoles Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 6.14 Global Echinocandins Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 6.15 Global Polyenes Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 7.1 Global Anti-infective Agents by Distribution Channel Market Share (%) 2018-2029
Figure 7.2 Global Anti-infective agents by Distribution Channel: Market Shares (%), 2018
Figure 7.3 Global Anti-infective agents by Distribution Channel: Market Shares (%), 2024
Figure 7.4 Global Anti-infective agents by Distribution Channel: Market Shares (%), 2029
Figure 7.5 Global Hospital Pharmacies Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 7.6 Global Retail Pharmacies Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 7.7 Global Online Sales Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 9.1 Global Anti-infective Agents Market by Region: Revenues (%), 2018
Figure 9.2 Global Anti-infective Agents Market by Region: Revenues (%), 2024
Figure 9.3 Global Anti-infective Agents Market by Region: Revenues (%), 2029
Figure 9.4 North America Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 9.5 North America Anti-infective Agents Market by Region Forecast: Market Share 2018-2029
Figure 9.6 US Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 9.7 Canada Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 9.8 Europe Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 9.9 Europe Anti-infective Agents Market by Country: Revenue (%), 2018-2029
Figure 9.10 Germany Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 9.11 UK Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 9.12 French Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 9.13 Rest of Europe Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Figure 9.14 Rest of Europe Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 9.15 Asia-Pacific Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 9.16 Asia-Pacific Anti-infective Agents Market by Country: Revenue (%), 2018-2029
Figure 9.17 Japanese Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 9.18 Chinese Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 9.19 Indian Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 9.20 Rest of APAC Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 9.21 Latin American Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 9.22 MEA Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 10.1 SWOT Analysis of the Global Anti-infective Agents Market, 2019-2029
Figure 11.1 Pfizer: Financial Overview: 2016-2018
Figure 11.2 Bristol-Myers Squibb Company: Financial Overview 2016- 2018
Figure 11.3 Merck & Co., Inc: Financial Overview 2016-2018
Figure 11.4 Novartis: Financial Overview 2016-2018
Figure 11.5 Sanofi S.A.: Financial Overview 2016-2018
Figure 12.1 Global Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%) 2019-2029
Figure 12.2 Global Anti-infective Agents Market Forecast Share (%) by Region 2018, 2024 & 2029
Abbott Laboratories
Allergan
Amplyx Pharmaceuticals
Arno Therapeutics
AureoGen Biosciences
Bristol-Myers Squibb
Celgene Corporation
Centers for Disease Control (CDC)
Cidara Therapeutics
Committee for Medicinal Products for Human Use (CHMP)
European Commission (EC)
European Medicines Agency (EMA)
Food and Drug Administration (FDA)
GlaxoSmithKline (GSK)
InnoPharma
Merck & Co., Inc.
Mirati Therapeutics
Novartis AG
Pfizer
Sanofi SA
Roche
Tokuyama Corporation
Vical
World Health Organization (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
